Evidence map›Paper›PMID 37987757›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2024

Distribution of P2Y and P2X purinergic receptor expression within the intestine.

Kristen A Engevik, Francesca J Scribano, J Thomas Gebert, Jacob L Perry, Sue E Crawford, Joseph M Hyser

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kristen A EngevikAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States.ORCID 0000-0001-9807-1875
Francesca J ScribanoAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States.ORCID 0000-0003-2178-6324
J Thomas GebertAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States.ORCID 0000-0001-9704-8972
Jacob L PerryAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States.ORCID 0000-0002-0630-9266
Sue E CrawfordAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States.
Joseph M HyserAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States.ORCID 0000-0001-5249-3482
Baylor College of Medicine · US

Funding

X-ray Crystallographic Studies on CalicivirusesP01AI057788 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI PRASAD, BIDADI VENKATARAM · 2004 to 2024
$34.4M
Novel Platforms for Human Intestinal Enteroids: Matrix, Mechanics, and TopographyU19AI116497 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI ESTES, MARY KOLB · 2015 to 2025
$13.2M
Regulation of Rotavirus ReplicationR01AI080656 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI Sue Ellen Crawford, Mary Kolb Estes · 2009 to 2026
$7.9M
Training Supplement in Enteric Virus Exploitation of Calcium SignalingR01DK115507 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Joseph M. Hyser · 2018 to 2026
$5.0M
Dissecting Rotavirus Viroporin and Enterotoxin Calcium Signaling PathwaysR01AI158683 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI CRAWFORD, SUE ELLEN, ESTES, MARY KOLB · 2021 to 2025
$2.0M
Regulation of Rotavirus ReplicationR56AI080656 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI ESTES, MARY KOLB · 2014 to 2014
$433k
The volume-regulated anion channel as a regulator of secretory activity in the intestinal epitheliumF30DK131828 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GEBERT, JOHN THOMAS · 2022 to 2024
$146k
Calcium signaling in Calicivirus infection and replicationF31DK132942 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI SCRIBANO, FRANCESCA JEAN · 2022 to 2024
$143k
Epithelial responses to rotavirus induced purinergic signalingF32DK130288 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI ENGEVIK, KRISTEN · 2021 to 2023
$118k
Role of Rotavirus NSP4 Viroporin and Enterotoxin Activity in Aberrant Calcium Signaling and ReplicationF31AI169983 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI PERRY, JACOB · 2022 to 2023
$93k
NIAID NIH HHS F31 AI169983NIAID NIH HHS P01 AI057788NIAID NIH HHS R01 AI080656NIAID NIH HHS R01 AI158683NIAID NIH HHS R56 AI080656NIAID NIH HHS U19 AI116497NIDDK NIH HHS F30 DK131828NIDDK NIH HHS F31 DK132942NIDDK NIH HHS F32 DK130288NIDDK NIH HHS R01 DK115507
6 · The paper itself

Abstract

Nucleotides are potent extracellular signaling molecules during homeostasis, infection, and injury due to their ability to activate purinergic receptors. The nucleotide ATP activates P2X receptors (P2RXs), whereas the nucleotides ADP, ATP, UTP, and UDP-glucose selectively activate different P2Y receptors (P2RYs). Several studies have established crucial roles for P2 receptors during intestinal inflammatory and infectious diseases, yet the most extensive characterization of purinergic signaling has focused on immune cells and the central and enteric nervous systems. As epithelial cells serve as the first barrier against irritants and infection, we hypothesized that the gut epithelium may express multiple purinergic receptors that respond to extracellular nucleotide signals. Using the Human Protein Atlas and Gut Cell Survey, we queried single-cell RNA sequencing (RNAseq) data for the P2 purinergic receptors in the small and large intestines. In silico analysis reveals robust mRNA expression of P2RY1, P2RY2, P2RY11, and P2RX4 throughout the gastrointestinal tract. Human intestinal organoids exhibited a similar expression pattern with a prominent expression of P2RY1, P2RY2, and P2RX4, but this purinergic receptor repertoire was not conserved in T84, Caco2, and HT29 intestinal epithelial cell lines. Finally, P2YR1 and P2YR2 agonists elicited robust calcium responses in human intestinal organoids, but calcium responses were weaker or absent in the cell lines. These findings suggest that the gastrointestinal epithelia respond to extracellular purinergic signaling via P2RY1, P2RY2, P2RY11, and P2RX4 receptors and highlight the benefit of using intestinal organoids as a model of intestinal purinergic signaling.

Indexed as

Adenosine TriphosphateCommunicable DiseasesCaco-2 CellsCalciumHumansNucleotidesReceptors, PurinergicReceptors, Purinergic P2Y2Adenosine TriphosphateCalciumNucleotidesP2RY2 protein, humanReceptors, PurinergicReceptors, Purinergic P2Y2gastrointestinal tractP2XP2Ypurinergic receptors

Identifiers

PMID37987757
PMCPMC11208031
OpenAlexW4388866438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.